Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?
Author:
Funder
the China National Natural Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Hepatology
Link
https://link.springer.com/content/pdf/10.1007/s12072-023-10597-8.pdf
Reference17 articles.
1. Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599
2. Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl. 2016;10:1–98
3. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HL, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–398
4. Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol. 2023;20(4):238–253
5. Li J, Fan P, Xu Z, Dong Y, Wang F, Hong W, et al. Functional cure of chronic hepatitis B with antiviral treatment in children having high-level viremia and normal or mildly elevated serum aminotransferase. J Clin Trans Hepatol. 2023. https://doi.org/10.14218/JCTH.2023.00014
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epidemiology, Natural History, and Outcome of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-07-30
2. Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-06-12
3. “Treat-all” Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?;Journal of Clinical and Translational Hepatology;2024-05-28
4. Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3